In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU chemical white paper moves forward

This article was originally published in The Rose Sheet

Executive Summary

European Parliament approves Commission White Paper on Strategy for a Future Chemicals Policy Nov. 15, paving the way for future legislation proposal to be developed in 2002, Parliament announces. Draft text should be finalized in late December, according to Rapporteur Inger Schörling's office. Paper, which calls for "better public information on all chemicals," would require comprehensive minimum data requirements for as many as 100,000 chemicals, including some used in cosmetics. Proposed safety assessments could necessitate animal testing, an allowance the European Cosmetic, Toiletry and Perfumery Association criticized as inconsistent and discriminatory in an Oct. 15 statement (1"The Rose Sheet" Nov. 12, In Brief)...

You may also be interested in...



EU Should Assess Risk Using Cosmetics Directive, Not Chemical Reg – CTFA

Risk assessment of raw materials used in cosmetics in the European Union should be addressed through the existing cosmetics directive rather than through a proposed chemical regulation, the Cosmetic, Toiletry and Fragrance Association states in comments to the European Commission

European Union animal testing reg

Commission Chemicals Policy White Paper is inconsistent with Parliament's position on animal testing in the Seventh Amendment to the cosmetics directive, European Cosmetic, Toiletry and Perfumery Association maintains in an Oct. 15 statement. "The principal of animal testing where indispensable is recognized in the White Paper on Chemicals: continuing to discriminate against the cosmetics industry on this point is not coherent," Colipa says, noting the cosmetics industry uses chemical ingredients. "Furthermore, it means concentrating on only .3% of the problem," Colipa adds. Chemicals Policy proposes safety assessments for roughly 100,000 chemical substances, which could necessitate animal testing, a measure that is banned under the proposed seventh amendment. The White Paper, which was adopted at the EU committee level Oct. 16, is scheduled for debate before full Parliament Nov. 14...

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009842

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel